Three musketeers of PDA-based MRI contrasting and therapy

References

• Sur S, Rathore A, Dave V, et al. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano Struct Nano Objects. 2019;20:100397. doi: 10.1016/j.nanoso.2019.100397.
   Google Scholar
• Indoria S, Singh V, Hsieh M-F. Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review. Int J Pharm. 2020;582:119314. doi: 10.1016/j.ijpharm.2020.119314.
   PubMed Web of Science ®Google Scholar
• Li L, Fu J, Wang X, et al. Biomimetic “nanoplatelets” as a targeted drug delivery platform for breast cancer theranostics. ACS Appl Mater Interfaces. 2021;13(3):3605–3621. doi: 10.1021/acsami.0c19259.
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu M, Deng F, et al. Recent progress and development on polymeric nanomaterials for photothermal therapy: a brief overview. J Mater Chem B. 2017;5(2):194–206. doi: 10.1039/C6TB02249A.
   PubMed Web of Science ®Google Scholar
• Tian L, Li X, Ji H, et al. Melanin-like nanoparticles: advances in surface modification and tumour photothermal therapy. J Nanobiotechnol. 2022;20(1):485. doi: 10.1186/s12951-022-01698-x.
   PubMed Web of Science ®Google Scholar
• Aguilar‐Ferrer D, Vasileiadis T, Iatsunskyi I, et al. Understanding the photothermal and photocatalytic mechanism of polydopamine coated gold nanorods. Adv Funct Mater. 2023;33:1–14. doi: 10.1002/adfm.202304208.
   Web of Science ®Google Scholar
• Beik J, Abed Z, Ghoreishi FS, et al. Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced applications. J Control Release. 2016;235:205–221. doi: 10.1016/j.jconrel.2016.05.062.
   PubMed Web of Science ®Google Scholar
• Pérez-Hernández M. Mechanisms of cell death induced by optical hyperthermia. In: R. M. Fratila and J. M. De La Fuente (editors). Nanomaterials for magnetic and optical hyperthermia applications. Elsevier; 2019. p. 201–228.
   Google Scholar
• Su J, Sun H, Meng Q, et al. Bioinspired nanoparticles with NIR‐controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer. Adv Funct Mater. 2016;26(41):7495–7506. doi: 10.1002/adfm.201603381.
   Web of Science ®Google Scholar
• Phung DC, Nguyen HT, Phuong Tran TT, et al. Combined hyperthermia and chemotherapy as a synergistic anticancer treatment. J Pharm Investig. 2019;49(5):519–526. doi: 10.1007/s40005-019-00431-5.
   Google Scholar
• Shen J, Lin M, Ding M, et al. Tumor immunosuppressive microenvironment modulating hydrogels for second near-infrared photothermal-immunotherapy of cancer. Mater Today Bio. 2022;16:100416. doi: 10.1016/j.mtbio.2022.100416.
   PubMedGoogle Scholar
• Zhang G, Chen X, Chen X, et al. Enhanced immunotherapy based on efficient tumor inhibition the synergistic click reaction-mediated chemotherapy and photothermal therapy for efficient tumor inhibition. Biol Med Chem. 2023:1–15. doi: 10.26434/chemrxiv-2023-nl43g.
   Google Scholar
• Overchuk M, Weersink RA, Wilson BC, et al. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17(9):7979–8003. doi: 10.1021/acsnano.3c00891.
   PubMed Web of Science ®Google Scholar
• Bienia A, Wiecheć-Cudak O, Murzyn AA, et al. Photodynamic therapy and hyperthermia in combination treatment—neglected forces in the fight against cancer. Pharmaceutics. 2021;13(8):1147. doi: 10.3390/pharmaceutics13081147.
   PubMed Web of Science ®Google Scholar
• Gao S, Wang G, Qin Z, et al. Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy. Biomaterials. 2017;112:324–335. doi: 10.1016/j.biomaterials.2016.10.030.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu W, Xiao P, et al. Molecular engineering of high-performance aggregation-Induced emission photosensitizers to boost cancer theranostics mediated by acid-triggered nucleus-targeted nanovectors. ACS Nano. 2021;15(6):10689–10699. doi: 10.1021/acsnano.1c03700.
   PubMed Web of Science ®Google Scholar
• Kim D, Jeong YY, Jon S. A drug-loaded aptamer–gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano. 2010;4(7):3689–3696. doi: 10.1021/nn901877h.
   PubMed Web of Science ®Google Scholar
• Yang C, Guo C, Guo W, et al. Multifunctional bismuth nanoparticles as theranostic agent for PA/CT imaging and NIR laser-driven photothermal therapy. ACS Appl Nano Mater. 2018;1(2):820–830. doi: 10.1021/acsanm.7b00255.
   Web of Science ®Google Scholar
• Yang J, Xie R, Feng L, et al. Hyperthermia and controllable free radical coenhanced synergistic therapy in hypoxia enabled by near-infrared-II light irradiation. ACS Nano. 2019;13(11):13144–13160. doi: 10.1021/acsnano.9b05985.
   PubMed Web of Science ®Google Scholar
• Kamkaew A, Cheng L, Goel S, et al. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2016;8(40):26630–26637. doi: 10.1021/acsami.6b10255.
   PubMed Web of Science ®Google Scholar
• Chen F, Hong H, Zhang Y, et al. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano. 2013;7(10):9027–9039. doi: 10.1021/nn403617j.
   PubMed Web of Science ®Google Scholar
• Lu W, Melancon MP, Xiong C, et al. Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res. 2011;71(19):6116–6121. doi: 10.1158/0008-5472.CAN-10-4557.
   PubMed Web of Science ®Google Scholar
• Krishna V, Singh A, Sharma P, et al. Polyhydroxy fullerenes for non‐invasive cancer imaging and therapy. Small. 2010;6(20):2236–2241. doi: 10.1002/smll.201000847.
   PubMed Web of Science ®Google Scholar
• Fernandes DA, Fernandes DD, Malik A, et al. Multifunctional nanoparticles as theranostic agents for therapy and imaging of breast cancer. J Photochem Photobiol B. 2021;218:112110. doi: 10.1016/j.jphotobiol.2020.112110.
   PubMed Web of Science ®Google Scholar
• Sharma S, Zvyagin A, Roy I. Theranostic applications of nanoparticle-mediated photoactivated therapies. J Nanotheranost. 2021;2(3):131–156. doi: 10.3390/jnt2030009.
   Google Scholar
• Lee HJ, Liu Y, Zhao J, et al. In vitro and in vivo mapping of drug release after laser ablation thermal therapy with doxorubicin-loaded hollow gold nanoshells using fluorescence and photoacoustic imaging. J Control Release. 2013;172(1):152–158. doi: 10.1016/j.jconrel.2013.07.020.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Dasgupta A, Chatterjee A, et al. The promise of magnetic resonance imaging in radiation oncology practice in the management of brain, prostate, and GI malignancies. JCO Glob Oncol. 2022;8:e2100366. doi: 10.1200/GO.21.00366.
   PubMedGoogle Scholar
• Zhao X, Shen R, Bao L, et al. Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer. Carbohydr Polym. 2020;245:116509. doi: 10.1016/j.carbpol.2020.116509.
   PubMed Web of Science ®Google Scholar
• Lau D, Corrie PG, Gallagher FA. MRI techniques for immunotherapy monitoring. J Immunother Cancer. 2022;10(9):e004708. doi: 10.1136/jitc-2022-004708.
   PubMed Web of Science ®Google Scholar
• McGowan JC. Basic principles of magnetic resonance imaging. Neuroimaging Clin N Am. 2008;18(4):623–636, x. doi: 10.1016/j.nic.2008.06.004.
   PubMed Web of Science ®Google Scholar
• Ju K-Y, Lee JW, Im GH, et al. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging. Biomacromolecules. 2013;14(10):3491–3497. doi: 10.1021/bm4008138.
   PubMed Web of Science ®Google Scholar
• Botta M, Geraldes CFGC, Tei L. High spin Fe(III)-doped nanostructures as T1 MR imaging probes. WIREs Nanomed Nanobiotechnol. 2023;15(2):1–19. doi: 10.1002/wnan.1858.
   Google Scholar
• Marasini R, Rayamajhi S, Moreno-Sanchez A, et al. Iron(III) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T1-weighted MRI contrast agent. RSC Adv. 2021;11(51):32216–32226. doi: 10.1039/D1RA05544E.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zou Y, Li Y, et al. Metal‐containing polydopamine nanomaterials: catalysis, energy, and theranostics. Small. 2020;16(18):e1907042. doi: 10.1002/smll.201907042.
   PubMed Web of Science ®Google Scholar
• Kaufman AA, Hansen RO, Kleinberg RLK. Chapter 6: paramagnetism, diamagnetism, and ferromagnetism. In: A.A. Kaufman, R.O. Hansen, R.L.K. Kleinberg (editors), Methods in geochemistry and geophysics; Elsevier, 2008. p. 207–254.
   Google Scholar
• Belorizky E, Fries PH. Characterising contrast agents for magnetic resonance imaging. In: P. Bertrand (editor), Electron paramagnetic resonance spectroscopy. Cham: Springer International Publishing; 2020. p. 313–349.
   Google Scholar
• Li M, Xuan Y, Zhang W, et al. Polydopamine-containing nano-systems for cancer multi-mode diagnoses and therapies: a review. Int J Biol Macromol. 2023;247(2023):125826. doi: 10.1016/j.ijbiomac.2023.125826.
   PubMedGoogle Scholar
• Liebscher J. Chemistry of polydopamine – scope, variation, and limitation. Eur J Org Chem. 2019;2019(31–32):4976–4994. doi: 10.1002/ejoc.201900445.
   Web of Science ®Google Scholar
• Zandieh M, Liu J. Metal-doped polydopamine nanoparticles for highly robust and efficient DNA adsorption and sensing. Langmuir. 2021;37(30):8953–8960. doi: 10.1021/acs.langmuir.1c00783.
   PubMed Web of Science ®Google Scholar
• Zandieh M, Liu J. Transition metal-mediated DNA adsorption on polydopamine nanoparticles. Langmuir. 2020;36(12):3260–3267. doi: 10.1021/acs.langmuir.0c00046.
   PubMed Web of Science ®Google Scholar
• Lemaster JE, Wang Z, Hariri A, et al. Gadolinium doping enhances the photoacoustic signal of synthetic melanin nanoparticles: a dual modality contrast agent for stem cell imaging. Chem Mater. 2019;31(1):251–259. doi: 10.1021/acs.chemmater.8b04333.
   PubMed Web of Science ®Google Scholar
• Bigaj-Józefowska MJ, Coy E, Załęski K, et al. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging. J Photochem Photobiol B. 2023;249:112813. doi: 10.1016/j.jphotobiol.2023.112813.
   PubMed Web of Science ®Google Scholar
• Qi C, Fu L-H, Xu H, et al. Melanin/polydopamine-based nanomaterials for biomedical applications. Sci China Chem. 2019;62(2):162–188. doi: 10.1007/s11426-018-9392-6.
   Web of Science ®Google Scholar
• Wang Z, Xie Y, Li Y, et al. Tunable, metal-loaded polydopamine nanoparticles analyzed by magnetometry. Chem Mater. 2017;29(19):8195–8201. doi: 10.1021/acs.chemmater.7b02262.
   Web of Science ®Google Scholar
• Li Y, Xie Y, Wang Z, et al. Structure and function of iron-loaded synthetic melanin. ACS Nano. 2016;10(11):10186–10194. doi: 10.1021/acsnano.6b05502.
   PubMed Web of Science ®Google Scholar
• Wu Y, Huang Y, Tu C, et al. A mesoporous polydopamine nanoparticle enables highly efficient manganese encapsulation for enhanced MRI-guided photothermal therapy. Nanoscale. 2021;13(13):6439–6446. doi: 10.1039/D1NR00957E.
   PubMed Web of Science ®Google Scholar
• Chen F, Xing Y, Wang Z, et al. Nanoscale polydopamine (PDA) meets π–π interactions: an interface-directed coassembly approach for mesoporous nanoparticles. Langmuir. 2016;32(46):12119–12128. doi: 10.1021/acs.langmuir.6b03294.
   PubMed Web of Science ®Google Scholar
• Tran S, DeGiovanni P-J, Piel B, et al. Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med. 2017;6(1):44. doi: 10.1186/s40169-017-0175-0.
   PubMed Web of Science ®Google Scholar
• Xing Y, Zhang J, Chen F, et al. Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy. Nanoscale. 2017;9(25):8781–8790. doi: 10.1039/C7NR01857F.
   PubMed Web of Science ®Google Scholar
• Suneetha M, Kim H, Han SS. Doxorubicin-loaded fungal-carboxymethyl chitosan functionalized polydopamine nanoparticles for photothermal cancer therapy. Pharmaceutics. 2023;15(4):1281. doi: 10.3390/pharmaceutics15041281.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang T, Liu Q, et al. Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy. Front Pharmacol. 2023;14:1081612. doi: 10.3389/fphar.2023.1081612.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang P, Guo R, et al. Multifunctional mesoporous polydopamine with hydrophobic paclitaxel for photoacoustic imaging-guided chemo-photothermal synergistic therapy. Int J Nanomedicine. 2019;14:8647–8663.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen H, Wang Y, et al. A novel self-coated polydopamine nanoparticle for synergistic photothermal-chemotherapy. Colloids Surf B Biointerfaces. 2021;200:111596. doi: 10.1016/j.colsurfb.2021.111596.
   PubMed Web of Science ®Google Scholar
• Dai L, Wei D, Zhang J, et al. Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer. Cell Prolif. 2021;54(11):e13130. doi: 10.1111/cpr.13130.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang L, Prabhakar N, et al. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy. Acta Biomater. 2019;86:416–428. doi: 10.1016/j.actbio.2019.01.002.
   PubMed Web of Science ®Google Scholar
• Wang L, He Y, He T, et al. Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers. Biomaterials. 2020;255:120208. doi: 10.1016/j.biomaterials.2020.120208.
   PubMed Web of Science ®Google Scholar
• Mu X, Zhang F, Kong C, et al. EGFR-targeted delivery of DOX-loaded Fe3O4@polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy. Int J Nanomedicine. 2017;12:2899–2911. doi: 10.2147/IJN.S131418.
   PubMed Web of Science ®Google Scholar
• Liu J, Yu X, Braucht A, et al. N-cadherin targeted melanin nanoparticles reverse the endothelial–mesenchymal transition in vascular endothelial cells to potentially slow the progression of atherosclerosis and cancer. ACS Nano. 2024;18(11):8229–8247. doi: 10.1021/acsnano.3c12281.
   PubMed Web of Science ®Google Scholar
• Liu J, Kang L, Smith S, et al. Transmembrane MUC18 targeted polydopamine nanoparticles and a mild photothermal effect synergistically disrupt actin cytoskeleton and migration of cancer cells. Nano Lett. 2021;21(22):9609–9618. doi: 10.1021/acs.nanolett.1c03377.
   PubMed Web of Science ®Google Scholar
• Liu G, Zhou N, Cheng L, et al. “Four-in-one” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy. Pharmaceutics. 2019;11(10):507. doi: 10.3390/pharmaceutics11100507.
   PubMed Web of Science ®Google Scholar
• Cao H, Jiang B, Yang Y, et al. Cell membrane covered polydopamine nanoparticles with two-photon absorption for precise photothermal therapy of cancer. J Colloid Interface Sci. 2021;604:596–603. doi: 10.1016/j.jcis.2021.07.004.
   PubMed Web of Science ®Google Scholar
• Pellico J, Ellis CM, Davis JJ. Nanoparticle-based paramagnetic contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging. 2019;2019:1845637. doi: 10.1155/2019/1845637.
   PubMed Web of Science ®Google Scholar
• Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40(11):715–724. doi: 10.1097/01.rli.0000184756.66360.d3.
   PubMed Web of Science ®Google Scholar
• Wang K, An L, Tian Q, et al. Gadolinium-labelled iron/iron oxide core/shell nanoparticles as T1–T2 contrast agent for magnetic resonance imaging. RSC Adv. 2018;8(47):26764–26770. doi: 10.1039/C8RA04530E.
   PubMed Web of Science ®Google Scholar
• Ding X, Liu J, Li J, et al. Polydopamine coated manganese oxide nanoparticles with ultrahigh relaxivity as nanotheranostic agents for magnetic resonance imaging guided synergetic chemo-/photothermal therapy. Chem Sci. 2016;7(11):6695–6700. doi: 10.1039/c6sc01320a.
   PubMed Web of Science ®Google Scholar
• Wang Z, Carniato F, Xie Y, et al. High relaxivity gadolinium-polydopamine nanoparticles. Small. 2017;13(43):1–7. doi: 10.1002/smll.201701830.
   Web of Science ®Google Scholar